This content is only available within our institutional offering.
11 May 2020
LIBERUM: UK Small & Mid Cap Dispatches
Rathbones Group PLC (RAT:LON), 1,562 | Cerillion Plc (CER:LON), 1,485 | Superdry PLC (SDRY:LON), 8.6 | WH Smith PLC (SMWH:LON), 1,233 | ASOS plc (ASC:LON), 355 | Gym Group Plc (GYM:LON), 109 | Loungers Plc (LGRS:LON), 213 | Science In Sport Plc (SIS:LON), 15.8 | J D Wetherspoon plc (JDW:LON), 727 | AstraZeneca PLC (AZN:LON), 10,953 | Bayer AG (BAYN:ETR), 0 | GSK plc (GSK:LON), 1,600 | Novartis AG (NOVN:SWX), 0 | Novo Nordisk A/S Class B (NOVO.B:CSE), 0 | Roche Holding Ltd Dividend Right Cert. (ROG:SWX), 0 | Sanofi (SAN:PAR), 0
Sign in
This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account
This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account
LIBERUM: UK Small & Mid Cap Dispatches
Rathbones Group PLC (RAT:LON), 1,562 | Cerillion Plc (CER:LON), 1,485 | Superdry PLC (SDRY:LON), 8.6 | WH Smith PLC (SMWH:LON), 1,233 | ASOS plc (ASC:LON), 355 | Gym Group Plc (GYM:LON), 109 | Loungers Plc (LGRS:LON), 213 | Science In Sport Plc (SIS:LON), 15.8 | J D Wetherspoon plc (JDW:LON), 727 | AstraZeneca PLC (AZN:LON), 10,953 | Bayer AG (BAYN:ETR), 0 | GSK plc (GSK:LON), 1,600 | Novartis AG (NOVN:SWX), 0 | Novo Nordisk A/S Class B (NOVO.B:CSE), 0 | Roche Holding Ltd Dividend Right Cert. (ROG:SWX), 0 | Sanofi (SAN:PAR), 0
- Published:
11 May 2020 -
Author:
Liberum Research Team -
Pages:
6